Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
Authors
Patrick M Boland
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
Patrick M Boland , Julia Quintanilha , Gerald Li , Allison Clark , Erik Carlson , Samantha Morley , Ali Aboosaiedi , Jerry W. Mitchell , Jeffrey S. Ross , Ryon Graf , Dustin A. Deming , Christopher Hanyoung Lieu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 207)
DOI
10.1200/JCO.2024.42.3_suppl.207
Abstract #
207
Poster Bd #
M15
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
First Author: Sandra Algaze
Poster
2017 ASCO Annual Meeting
Variability in genomic alterations between right- and left-sided microsatellite stable (MSS) metastatic colorectal cancer and impact on survival.
First Author: Rona Yaeger
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua